These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 8689381

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Neuroleptic malignant syndrome in users of risperidone].
    Bonte-Mineur F, Geerlings CJ, Rietveld AP.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):158-9; author reply 159. PubMed ID: 15693595
    [No Abstract] [Full Text] [Related]

  • 3. [Neuroleptic malignant syndrome in users of risperidone].
    van Bemmel T, Westendorp RG.
    Ned Tijdschr Geneeskd; 2005 Mar 12; 149(11):608; author reply 608. PubMed ID: 15799646
    [No Abstract] [Full Text] [Related]

  • 4. [Neuroleptic malignant syndrome in users of risperidone].
    van Waarde JA, Kuiper J, Verwey B.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):156-7; author reply 157. PubMed ID: 15693593
    [No Abstract] [Full Text] [Related]

  • 5. [Neuroleptic malignant syndrome in users of risperidone].
    Kroon JG.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):157-8; author reply 158. PubMed ID: 15693594
    [No Abstract] [Full Text] [Related]

  • 6. Comment: neuroleptic malignant syndrome associated with risperidone and fluvoxamine.
    Isbister GK, Dawson AH, Whyte IM.
    Ann Pharmacother; 2002 Jan 15; 36(7-8):1293; author reply 1294. PubMed ID: 12086569
    [No Abstract] [Full Text] [Related]

  • 7. [Neuroleptic malignant syndrome in users of risperidone].
    Vorel SK, Bos F, Vorel-Havelkova E, Brombacher PJ.
    Ned Tijdschr Geneeskd; 2005 Jan 15; 149(3):159-60; author reply 160. PubMed ID: 15693596
    [No Abstract] [Full Text] [Related]

  • 8. Atypical neuroleptic malignant syndrome associated with risperidone treatment in two adolescents.
    Zalsman G, Lewis R, Konas S, Loebstein O, Goldberg P, Burguillo F, Nahshoni E, Munitz H.
    Int J Adolesc Med Health; 2004 Jan 15; 16(2):179-82. PubMed ID: 15266995
    [Abstract] [Full Text] [Related]

  • 9. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY, Wu PC, Chen CY, Chen YC.
    Gen Hosp Psychiatry; 2011 Jan 15; 33(1):84.e5-7. PubMed ID: 21353143
    [Abstract] [Full Text] [Related]

  • 10. Neuroleptic malignant syndrome with risperidone.
    Levin GM, Lazowick AL, Powell HS.
    J Clin Psychopharmacol; 1996 Apr 15; 16(2):192-3. PubMed ID: 8690838
    [No Abstract] [Full Text] [Related]

  • 11. Neuroleptic malignant syndrome with risperidone.
    Gleason PP, Conigliaro RL.
    Pharmacotherapy; 1997 Apr 15; 17(3):617-21. PubMed ID: 9165568
    [Abstract] [Full Text] [Related]

  • 12. Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique.
    Hasan S, Buckley P.
    Am J Psychiatry; 1998 Aug 15; 155(8):1113-6. PubMed ID: 9699705
    [Abstract] [Full Text] [Related]

  • 13. [The risperidone-associated neuroleptic malignant syndrome in a pediatric patient].
    Villanueva Lamas J, García García J, Alda Diez JA, Tous Andreu N.
    An Esp Pediatr; 1998 Dec 15; 49(6):652-3. PubMed ID: 9972639
    [No Abstract] [Full Text] [Related]

  • 14. Risperidone and NMS?
    Murray S, Haller E.
    Psychiatr Serv; 1995 Sep 15; 46(9):951. PubMed ID: 7583513
    [No Abstract] [Full Text] [Related]

  • 15. Atypical neuroleptic malignant syndrome associated with risperidone treatment.
    Newman M, Adityanjee, Jampala C.
    Am J Psychiatry; 1997 Oct 15; 154(10):1475. PubMed ID: 9326841
    [No Abstract] [Full Text] [Related]

  • 16. Neuroleptic Malignant Syndrome After Early Administration of Risperidone Long-Acting Injection.
    Mitchell BG, McMahon BC, Mitchell CW.
    Prim Care Companion CNS Disord; 2017 Nov 30; 19(6):. PubMed ID: 29195036
    [No Abstract] [Full Text] [Related]

  • 17. Case study. Risperidone-Induced neuroleptic malignant syndrome in an adolescent.
    Robb AS, Chang W, Lee HK, Cook MS.
    J Child Adolesc Psychopharmacol; 2000 Nov 30; 10(4):327-30. PubMed ID: 11191694
    [Abstract] [Full Text] [Related]

  • 18. Diabetic ketoacidosis, neuroleptic malignant syndrome, and myocardial infarction in a patient taking risperidone and lithium carbonate.
    Ananth J, Johnson KM, Levander EM, Harry JL.
    J Clin Psychiatry; 2004 May 30; 65(5):724. PubMed ID: 15163265
    [No Abstract] [Full Text] [Related]

  • 19. Risperidone-induced neuroleptic malignant syndrome: a case report and review.
    Meterissian GB.
    Can J Psychiatry; 1996 Feb 30; 41(1):52-4. PubMed ID: 8919425
    [Abstract] [Full Text] [Related]

  • 20. [Neuroleptic malignant syndrome in users of risperidone].
    Gerritsen AA, de Jonghe-Rouleau AP, Stienstra-Liem LH.
    Ned Tijdschr Geneeskd; 2004 Sep 11; 148(37):1801-4. PubMed ID: 15495506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.